Speaker at International Conference and Expo on Toxicology and Applied Pharmacology Conference  2022 - Dibyajyoti Banerjee
Postgraduate Institute of Medical Education and Research, India
Title : Human Serum Albumin and cholesterol: A new thought


Among non-communicable diseases the cardiovascular disorders are topping the list. Hypercholesterolemia is one of the important risk factors for the genesis of cardiovascular diseases. The cholesterol biosynthesis is attempted to be blocked by various drugs but neither hypercholesterolemia or cholesterol associated disorders are getting controlled. So, it seems that our understanding of the regulation of the cholesterol biosynthesis is mostly incomplete. It is in this context we have developed a hypothesis that human serum albumin can regulate cholesterol biosynthesis. In my talk I shall discuss the toxicological and pharmacological aspects of the above concept.


Dr Dibyajyoti Banerjee, MD is currently Additional Professor, Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, PGIMER, Chandigarh, India. He is interested in developing novel concepts for drug development and his several concepts are published and many researchers are working with it. His focus in drug development is diabetes and tuberculosis. Apart from drug development he is interested in developing point of care testing tools. In this area also he has developed several tools which are in current use.